Prelude Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-430	Closed	-$250K	–	1441
2025 Q4	$250K	Buy	+430	New	+$220K	0.02%	891
2024 Q3	–	Sell	-2,500	Closed	-$700K	–	1459
2024 Q2	$700K	Buy	2,500 +464	+23%	+$110K	0.06%	398
2024 Q1	$544K	Sell	2,036 -964	-32%	-$227K	0.04%	603
2023 Q4	$694K	Buy	3,000 +981	+49%	+$172K	0.06%	401
2023 Q3	$295K	Buy	2,019 +678	+51%	+$128K	0.03%	678
2023 Q2	$310K	Buy	+1,341	New	+$363K	0.03%	629
2019 Q3	–	Hold	0	–	–	–	2010
2019 Q2	–	Hold	0	–	–	–	2021
2019 Q1	–	Hold	0	–	–	–	2066
2018 Q4	–	Hold	0	–	–	–	2069
2018 Q3	–	Sell	-25	Closed	-$6.27K	–	1970
2018 Q2	$7K	Buy	+25	New	+$4.39K	﹤0.01%	1529